Concepedia

Neoantigen Profiling

Neoantigen Profiling is a molecular tumor profiling method that identifies tumor-specific antigens arising from somatic mutations by predicting immunogenic peptides presented on cancer cell surfaces through computational analysis of genomic and transcriptomic data.

64

Publications

4.8K

Citations

767

Authors

279

Institutions

Publications per year

2017–2026

55

Parents

Publications

64

Association of Polymerase e–Mutated and Microsatellite-Instable Endometrial Cancers With Neoantigen Load, Number of Tumor-Infiltrating Lymphocytes, and Expression of PD-1 and PD-L1

Brooke E. Howitt, Sachet A. Shukla, Lynette M. Sholl et al. · JAMA Oncology · 2015 · 685 citations · Full text

, , +17

Genomic and bioinformatic profiling of mutational neoepitopes reveals new rules to predict anticancer immunogenicity

Fei Duan, Jorge Duitama, Sahar Al Seesi et al. · The Journal of Experimental Medicine · 2014 · 395 citations

, , +17

Deep learning using tumor HLA peptide mass spectrometry datasets improves neoantigen identification

Brendan Bulik‐Sullivan, Jennifer Busby, Christine D. Palmer et al. · Nature Biotechnology · 2018 · 310 citations

, , +17

Antigen presentation profiling reveals recognition of lymphoma immunoglobulin neoantigens

Michael S. Khodadoust, Niclas Olsson, Lisa E. Wagar et al. · Nature · 2017 · 263 citations

, , +16

Stratification of Pancreatic Ductal Adenocarcinoma: Combinatorial Genetic, Stromal, and Immunologic Markers

Erik S. Knudsen, Paris Vail, Uthra Balaji et al. · Clinical Cancer Research · 2017 · 190 citations · Full text

, , +17

1–5 of 64

Authors

767

  1. MA
    Mark Ayers

    Merck & Co., Inc., Rahway, NJ, USA (United States), United States

    3 publications · 167 citations

    3

    h-index

  2. RM
    Robin Mogg

    Merck & Co., Inc., Rahway, NJ, USA (United States), United States

    3 publications · 167 citations

    3

    h-index

  3. AA
    Andrew Albright

    Merck & Co., Inc., Rahway, NJ, USA (United States), United States

    3 publications · 167 citations

    3

    h-index

  4. SA
    Sachet A. Shukla

    Dana-Farber Cancer Institute, United States

    3 publications · 736 citations

    3

    h-index

  5. KK
    Kazuhiro Kakimi

    University of Tokyo Hospital, Japan

    3 publications · 144 citations

    3

    h-index

1–5 of 767

Institutions

279

  1. Dana-Farber Cancer Institute

    Boston, United States

    10 h-index

    32 publications

    4.8K citations

  2. Johns Hopkins University

    Baltimore, United States

    7 h-index

    9 publications

    782 citations

  3. Harvard University

    Cambridge, United States

    5 h-index

    24 publications

    8.7K citations

  4. The University of Texas MD Anderson Cancer Center

    Houston, United States

    5 h-index

    44 publications

    2.8K citations

  5. Memorial Sloan Kettering Cancer Center

    New York, United States

    5 h-index

    23 publications

    2K citations

  6. Broad Institute

    Cambridge, United States

    4 h-index

    13 publications

    1.6K citations

  7. Merck & Co., Inc., Rahway, NJ, USA (United States)

    Rahway, United States

    4 h-index

    28 publications

    1.2K citations

  8. University of Chicago

    Chicago, United States

    4 h-index

    10 publications

    489 citations

1–8 of 279

Venues

  1. Journal for ImmunoTherapy of Cancer

    JITC · 8 publications · 363 citations

    8

    h-index

  2. OncoImmunology

    5 publications · 290 citations

    5

    h-index

  3. Scientific Reports

    5 publications · 383 citations

    5

    h-index

  4. Journal of Clinical Oncology

    4 publications · 105 citations

    4

    h-index

  5. Theranostics

    2 publications · 45 citations

    2

    h-index

1–5